Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
26.92
-1.10 (-3.93%)
At close: May 19, 2026, 4:00 PM EDT
26.80
-0.12 (-0.43%)
Pre-market: May 20, 2026, 7:22 AM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $54.11. The average 1-year stock price forecast is 101.00% higher than the current stock price, while the lowest is $38 (+41.16%) and the highest is $63 (+134.03%).
Price Target: $54.11 (+101.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +122.88% | May 13, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +134.03% | Mar 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $45 → $58 | Buy | Reiterates | $45 → $58 | +115.45% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +122.88% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +122.88% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
84.92M
Revenue Next Year
113.95M
from 84.92M
Increased by 34.19%
EPS This Year
-0.66
from -2.26
EPS Next Year
-0.79
from -0.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 224.0M | 191.8M | ||||||
| Avg | 84.9M | 114.0M | ||||||
| Low | n/a | 31.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 125.9% | ||||||
| Avg | - | 34.2% | ||||||
| Low | - | -62.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.54 | 0.65 | ||||||
| Avg | -0.66 | -0.79 | ||||||
| Low | -2.47 | -2.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.